Skip to main content

ICES-Institute for clinical evaluative sciences

Chronic Disease & Pharmacotherapy Research Program

Program Lead: Michael Paterson
Program Coordinator: CDPadmin@ices.on.ca

The Chronic Disease and Pharmacotherapy (CDP) research program has two main areas of emphasis.  In the chronic disease area, scientists track the epidemiology, management and outcomes of chronic illnesses. Such illnesses include diabetes, arthritis, asthma and chronic obstructive pulmonary disease. The CDP program tracks these illnesses over time and among population subgroups and geographic areas.
In the area of pharmacotherapy, cutting-edge epidemiologic methods are used to examine the real-world use, safety and effectiveness of prescription drugs and drug insurance policies.


Announcements & Events

See all CDP Announcements & Events


Recent Publications


Recent ICES Grants


COLLABORATIONS AND PARTNERsHIPS

The Chronic Disease and Pharmacotherapy program has many importants colloborations and partnerships. Below is a list of some our partnerships.

Canadian Network for Observation Drug Effect Studeis (CNODES)

Ontario Drug Policy Research Network 

Ontario Drug Policy Research Network (ODPRN)

Ontario Asthma Surveillance Information System (OASIS)

Arthritis Community Research & Evaluation Unit (ACREU)

Ontario Best Practices Research Initiative (OBRI)

Toronto Health Economics and Technology Assessment (THETA) Collaborative


Recent Awards & Recognition

  • Canada Research Chair

    2020: Dr. Gillian Booth named Canada Research Chair in Policy Solutions for Diabetes Prevention and Management.

  • Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment

    2020: Awarded to Dr. Wendy Ungar by CADTH. The award recognizes an individual who has significantly advanced the field of health technology assessment in Canada.

  • Banting and Best Diabetes Centre New Investigator Award

    2020: Dr. Alanna Weisman awarded the Sun Life Financial New Investigator Award for Diabetes Research for the project "Real-World Feasibility of the Hemoglobin A1c Target of ≤7.0% in Type 1 Diabetes: A Retrospective, Population-Based Cohort Study"


Trainee Success

Dissertation Defence

September 2013
Bheeshma Ravi
Degree: PhD in the Institute of Health Policy, Management and Evaluation, University of Toronto
Dissertation: Complications following total joint arthroplasty in patients with rheumatoid arthritis

Recent Graduations

June 2013
Jessica Widdifield
Degree: PhD in the Institute of Health Policy, Management and Evaluation, University of Toronto
Dissertation: Accuracy of Ontario administrative health data in identifying patients with rheumatoid arthritis


ICES Scientists


×